Rheumatoid Arthritis Market Research Report – Forecast to 2022 Global Industry Survey, Growth, Competitive Landscape and Forecasts to 2022 CREATED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

Rheumatoid Arthritis Market Research Report – Forecast to 2022 Rheumatoid Arthritis Market Overview Market Research Future (MRFR) has published a research report that predicts success for the global rheumatoid arthritis market with 4% CAGR (Compound Annual Growth Rate) between 2017 and Analyzing the market structure, this report evaluates the future growth potential and observes the strategies of the key players in this market. It also tracks the competitive developments such as joint ventures, mergers, and acquisitions, new product developments, new product developments (R & D) in the market. According to a study, the women are three times more prone to this disease than men. The key factors that can impact the market growth include a high number of individuals suffering from the autoimmune disease. Browse Report

Segmentation : Global rheumatoid arthritis market has been segmented on the basis of drug type which comprises of Non-steroidal anti-inflammatory drug type (NSAID), Steroids, and Disease-modifying anti-rheumatic drug type (DMARDs) and Biologic agents. On the basis of treatment include Synovectomy, Tendon repair, Joint fusion and Total joint replacement. Furthermore on the basis of diagnosis includes C - reactive protein (CRP) Test, CCP, ESR (Erythrocyte Sedimentation Rate) Test and Synovial Fluid Analysis. Request a Sample Rheumatoid Arthritis Market Research Report – Forecast to 2022

Application & Major Players in this Research: Market Prominent Players: Some of the key players in this market are: Pfizer Inc (U.S), Eli Lilly and company (U.S), Bristol-Myers Squibb Company (U.S), F. Hoffmann-La Roche Ltd (switzerland), Novartis AG (switzerland), Vertex Pharmaceuticals Incorporated (U.S), Sanofi (France), AstraZeneca (U.K) and many others. Commenting on the report, an analyst from Market Research Future (MRFR)’s team said: The competitive market is witnessing several strategies such as mergers and collaborations that could take the market forward. For instance, Illumina bought Edico Genome, a data analysis company that provides solutions for NGS. Myriad Genetics acquired Counsyl, a specialist in carrier screening and non-invasive prenatal screening. Get Rheumatoid Arthritis Market Research Report – Forecast to 2022

About Us: Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous- Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit or contact us at Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. Rheumatoid Arthritis Market Research Report – Forecast to 2022

MARKET RESEARCH FUTURE THANK YOU Ph: (US) Ph: (UK)